Turmeric (Haldi)
Curcumin, the active compound in turmeric, directly interferes with inflammatory pathways that degrade insulin signalling. A 2012 randomised controlled trial published in Diabetes Care followed 240 prediabetic adults over nine months: those given daily curcumin supplements showed zero progression to type 2 diabetes, while 16.4% of the placebo group did. The mechanism is specific, curcumin activates AMPK, an enzyme that mimics the metabolic effect of exercise on glucose uptake in muscle cells.